Signalling a growing interest in new drug discovery research, some major Indian pharmaceutical firms had applied for conducting clinical trials on at least 12 new drugs in 2010.The most sought......
Piramal Healthcare on Wednesday said it has completed the sale of its domestic formulations business to US-based Abbott Healthcare and has received Rs 10,271 crore (Rs 102.71 billion) as initial......
Piramal Healthcare is planning a string of acquisitions in the biotech space in the US, Europe and Canada in the next two to three years. The company intends to make up for the Rs 2,000-crore (Rs......
Swati Piramal, director of Piramal Healthcare, was elected president of Assocham on Friday. Piramal, who replaces Sajjan Jindal, was seenior vice-president of the industry body. Harvard-educated......
Piramal Healthcare's drug discovery arm, Piramal Life Sciences Ltd, is planning to move at least three more novel chemical entities under development into the human clinical trial stage within the......